4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Annotating Transcriptional Effects of Genetic Variants in Disease‐Relevant Tissue: Transcriptome‐Wide Allelic Imbalance in Osteoarthritic Cartilage

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          Multiple single‐nucleotide polymorphisms ( SNPs) conferring susceptibility to osteoarthritis ( OA) mark imbalanced expression of positional genes in articular cartilage, reflected by unequally expressed alleles among heterozygotes (allelic imbalance [ AI]). We undertook this study to explore the articular cartilage transcriptome from OA patients for AI events to identify putative disease‐driving genetic variation.

          Methods

          AI was assessed in 42 preserved and 5 lesioned OA cartilage samples (from the Research Arthritis and Articular Cartilage study) for which RNA sequencing data were available. The count fraction of the alternative alleles among the alternative and reference alleles together ( φ) was determined for heterozygous individuals. A meta‐analysis was performed to generate a meta‐ φ and P value for each SNP with a false discovery rate ( FDR) correction for multiple comparisons. To further validate AI events, we explored them as a function of multiple additional OA features.

          Results

          We observed a total of 2,070 SNPs that consistently marked AI of 1,031 unique genes in articular cartilage. Of these genes, 49 were found to be significantly differentially expressed (fold change <0.5 or >2, FDR <0.05) between preserved and paired lesioned cartilage, and 18 had previously been reported to confer susceptibility to OA and/or related phenotypes. Moreover, we identified notable highly significant AI SNPs in the CRLF1 , WWP2 , and RPS3 genes that were related to multiple OA features.

          Conclusion

          We present a framework and resulting data set for researchers in the OA research field to probe for disease‐relevant genetic variation that affects gene expression in pivotal disease‐affected tissue. This likely includes putative novel compelling OA risk genes such as CRLF1 , WWP2 , and RPS3 .

          Related collections

          Most cited references37

          • Record: found
          • Abstract: found
          • Article: not found

          Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development.

          Chondrocyte hypertrophy followed by cartilage matrix degradation and vascular invasion, characterized by expression of type X collagen (COL10A1), matrix metalloproteinase-13 (MMP-13) and vascular endothelial growth factor (VEGF), respectively, are central steps of endochondral ossification during normal skeletal growth and osteoarthritis development. A COL10A1 promoter assay identified hypoxia-inducible factor-2alpha (HIF-2alpha, encoded by EPAS1) as the most potent transactivator of COL10A1. HIF-2alpha enhanced promoter activities of COL10A1, MMP13 and VEGFA through specific binding to the respective hypoxia-responsive elements. HIF-2alpha, independently of oxygen-dependent hydroxylation, was essential for endochondral ossification of cultured chondrocytes and embryonic skeletal growth in mice. HIF-2alpha expression was higher in osteoarthritic cartilages versus nondiseased cartilages of mice and humans. Epas1-heterozygous deficient mice showed resistance to osteoarthritis development, and a functional single nucleotide polymorphism (SNP) in the human EPAS1 gene was associated with knee osteoarthritis in a Japanese population. The EPAS1 promoter assay identified RELA, a nuclear factor-kappaB (NF-kappaB) family member, as a potent inducer of HIF-2alpha expression. Hence, HIF-2alpha is a central transactivator that targets several crucial genes for endochondral ossification and may represent a therapeutic target for osteoarthritis.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study.

            We conducted a sib pair study in very old subjects for the purpose of mapping longevity loci. In the present analysis, we explore whether our recruitment strategy has resulted in a population enriched for a heritable component for exceptional longevity. Our study includes families with at least two long-living siblings (men aged 89 years or above; women aged 91 years or above). Data were collected on date of birth and, if applicable, date of death of parents, brothers and sisters, offspring, and spouses of the long-living participants. Standardised mortality ratios (SMRs) compared with the general Dutch population, were calculated. The SMR for all siblings of the long-living participants was 0.66 (95% CI 0.60-0.73). A similar survival benefit was also observed in the parents (SMR=0.76, 95% CI 0.66-0.87) and in the offspring of the long-living subjects (SMR=0.65, 95% CI 0.51-0.80). The SMR of the spouses of the long-living subjects was 0.95 (95% CI 0.82-1.12). The familial clustering of extended survival is unlikely to be caused by ascertainment bias, because in all analyses the long-living participants were excluded. Moreover, it is also unlikely to be caused by environmental factors, because the spouses of the long-living participants had a mortality risk comparable with the general Dutch population, whereas they share the same environment. We conclude that our sample is genetically enriched for extreme survival.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Senescent cells and osteoarthritis: a painful connection

              Senescent cells (SnCs) are associated with age-related pathologies. Osteoarthritis is a chronic disease characterized by pain, loss of cartilage, and joint inflammation, and its incidence increases with age. For years, the presence of SnCs in cartilage isolated from patients undergoing total knee artificial implants has been noted, but these cells’ relevance to disease was unclear. In this Review, we summarize current knowledge of SnCs in the multiple tissues that constitute the articular joint. New evidence for the causative role of SnCs in the development of posttraumatic and age-related arthritis is reviewed along with the therapeutic benefit of SnC clearance. As part of their senescence-associated secretory phenotype, SnCs secrete cytokines that impact the immune system and its response to joint tissue trauma. We present concepts of the immune response to tissue trauma as well as the interactions with SnCs and the local tissue environment. Finally, we discuss therapeutic implications of targeting SnCs in treating osteoarthritis.
                Bookmark

                Author and article information

                Contributors
                i.meulenbelt@lumc.nl
                Journal
                Arthritis Rheumatol
                10.1002/(ISSN)2326-5205
                ART
                Arthritis & Rheumatology (Hoboken, N.j.)
                John Wiley and Sons Inc. (Hoboken )
                2326-5191
                2326-5205
                23 February 2019
                April 2019
                : 71
                : 4 ( doiID: 10.1002/art.2019.71.issue-4 )
                : 561-570
                Affiliations
                [ 1 ] Leiden University Medical Center Leiden The Netherlands
                [ 2 ] Radboud University Medical Center Nijmegen, The Netherlands, and Wellcome Trust Centre for Human Genetics Oxford UK
                [ 3 ] Erasmus Medical Center Rotterdam The Netherlands
                [ 4 ] Radboud University Medical Center Nijmegen Nijmegen The Netherlands
                Author notes
                [*] [* ]Address correspondence to Ingrid Meulenbelt, PhD, Department of Medical Statistics and Bioinformatics, Section of Molecular Epidemiology, Leiden University Medical Center, LUMC Post‐zone S‐05‐P, PO Box 9600, 2300 RC Leiden, The Netherlands. E‐mail: i.meulenbelt@ 123456lumc.nl .
                Author information
                https://orcid.org/0000-0001-7786-7081
                Article
                ART40748
                10.1002/art.40748
                6593438
                30298554
                976ca349-681c-4c3a-83ce-b7b90f4b04b9
                © 2018 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 16 May 2018
                : 02 October 2018
                Page count
                Figures: 3, Tables: 2, Pages: 10, Words: 8324
                Funding
                Funded by: Dutch Arthritis Society
                Award ID: DAA 10‐1‐402
                Funded by: Dutch Scientific Research Council NWO ZonMW VICI
                Award ID: 91816631 / 528
                Funded by: European Commission Seventh Framework Programme
                Award ID: 200800
                Funded by: Leiden University Medical Center
                Categories
                Original Article
                Osteoarthritis
                Custom metadata
                2.0
                art40748
                April 2019
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.5 mode:remove_FC converted:26.06.2019

                Comments

                Comment on this article